Molecular Testing IDIQ-Qiagen Brand Name 36C24425Q0942
Summary
AI-generated · Sep 12, 2025Provide all resources necessary to accomplish the deliverables described in the PWS by supplying reagents, quality-control materials, linearity and validation reagents for testing and detecting mutations in biomarkers associated with specific cancer types in the molecular anatomic pathology department. The targeted assays are KRAS RGQ PCR, EGFR RGQ PCR, BRAF RGQ PCR, and IDH1/2 RGQ PCR.
Reagents must be Qiagen brand-name to ensure compatibility with the Rotor-Gene Q MDx analyzers’ software currently onsite at VA Pittsburgh Healthcare System. The award will be a 5-year IDIQ contract with 12-month ordering periods.
The contractor shall provide all resources necessary to accomplish the deliverables described in this PWS by suppyling reagents, quality control materials, linearity and balidation reagents, for testing and detecting mutations in biomarkers assoicated with specific types of cancer in our molecular anatomic patholoy department. These reagents are KRAS RGQ PCR, EGFR RGQ PCR, BRAF RGQ PCR, and IDH 1/2 RGQ PCR. the reagents MUST be QIAGEN Brand Name to be compatible with the Rotor-Gene Q MDx analyzers proprietary software currently onsite at VA Pittsburgh Healthcare System. The award will be a 5 year IDIQ contract with 12-month ordering periods.
From Solicitation posted on Sep 11, 2025Notice history
1-
Solicitation LATEST Posted Sep 11, 2025
Details
Award Information
Not yet awarded
Contacts
Phone
Agency
Place of Performance
USA